Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 523

1.

Autologous cell replacement: a noninvasive AI approach to clinical release testing.

Tucker BA, Mullins RF, Stone EM.

J Clin Invest. 2020 Jan 21. pii: 133821. doi: 10.1172/JCI133821. [Epub ahead of print]

2.

Models and Impacts of Science Research Experiences: A Review of the Literature of CUREs, UREs, and TREs.

Krim JS, Coté LE, Schwartz RS, Stone EM, Cleeves JJ, Barry KJ, Burgess W, Buxner SR, Gerton JM, Horvath L, Keller JM, Lee SC, Locke SM, Rebar BM.

CBE Life Sci Educ. 2019 Dec;18(4):ar65. doi: 10.1187/cbe.19-03-0069.

3.

AUTOIMMUNE RETINOPATHY MIMICKING HERITABLE RETINAL DEGENERATION IN A PATIENT WITH COMMON VARIABLE IMMUNE DEFICIENCY.

Wiley LA, Binkley EM, DeLuca AP, Workalemahu G, Tatro NJ, Luse MA, Kennedy EL, Folk JC, Scheetz TE, Ballas ZK, Tucker BA, Mullins RF, Han IC, Stone EM.

Retin Cases Brief Rep. 2019 Nov 21. doi: 10.1097/ICB.0000000000000941. [Epub ahead of print]

PMID:
31764884
4.

Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration.

Voigt AP, Mulfaul K, Mullin NK, Flamme-Wiese MJ, Giacalone JC, Stone EM, Tucker BA, Scheetz TE, Mullins RF.

Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24100-24107. doi: 10.1073/pnas.1914143116. Epub 2019 Nov 11.

5.

Scleral pits represent degeneration around the posterior ciliary arteries and are signs of disease severity in choroideremia.

Harvey CM, Whitmore SS, Critser DB, Affatigato LM, Daggett HT, Stone EM, Han IC.

Eye (Lond). 2019 Sep 25. doi: 10.1038/s41433-019-0599-4. [Epub ahead of print]

PMID:
31554944
6.

Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11.

Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, Liao P, Zhou J, Zhang Q, Dow A, Saripalli AL, Kryczek I, Wei S, Szeliga W, Vatan L, Stone EM, Georgiou G, Cieslik M, Wahl DR, Morgan MA, Chinnaiyan AM, Lawrence TS, Zou W.

Cancer Discov. 2019 Dec;9(12):1673-1685. doi: 10.1158/2159-8290.CD-19-0338. Epub 2019 Sep 25.

7.

The Policy Ecology of Behavioral Health Homes: Case Study of Maryland's Medicaid Health Home Program.

Stone EM, Daumit GL, Kennedy-Hendricks A, McGinty EE.

Adm Policy Ment Health. 2020 Jan;47(1):60-72. doi: 10.1007/s10488-019-00973-8.

PMID:
31506860
8.

Trends In Public Opinion On US Gun Laws: Majorities Of Gun Owners And Non-Gun Owners Support A Range Of Measures.

Barry CL, Stone EM, Crifasi CK, Vernick JS, Webster DW, McGinty EE.

Health Aff (Millwood). 2019 Oct;38(10):1727-1734. doi: 10.1377/hlthaff.2019.00576. Epub 2019 Sep 9.

PMID:
31498657
9.

Differences in public support for handgun purchaser licensing.

Crifasi CK, Stone EM, McGinty B, Vernick JS, Barry CL, Webster DW.

Inj Prev. 2020 Feb;26(1):93-95. doi: 10.1136/injuryprev-2019-043405. Epub 2019 Sep 6.

PMID:
31492689
10.

Helper-Dependent Adenovirus Transduces the Human and Rat Retina but Elicits an Inflammatory Reaction When Delivered Subretinally in Rats.

Han IC, Burnight ER, Ulferts MJ, Worthington KS, Russell SR, Sohn EH, Mullins RF, Stone EM, Tucker BA, Wiley LA.

Hum Gene Ther. 2019 Nov;30(11):1371-1384. doi: 10.1089/hum.2019.159. Epub 2019 Sep 26.

PMID:
31456426
11.

U.S. news media coverage of solutions to the opioid crisis, 2013-2017.

McGinty EE, Stone EM, Kennedy-Hendricks A, Sanders K, Beacham A, Barry CL.

Prev Med. 2019 Sep;126:105771. doi: 10.1016/j.ypmed.2019.105771. Epub 2019 Jul 17.

PMID:
31325526
12.

Cognitive but Not Affective Theory of Mind Deficits in Progressive MS.

Lancaster K, Stone EM, Genova HM.

J Int Neuropsychol Soc. 2019 Sep;25(8):896-900. doi: 10.1017/S1355617719000584. Epub 2019 Jun 14.

PMID:
31196250
13.

Effect of pill mill laws on opioid overdose deaths in Ohio & Tennessee: A mixed-methods case study.

Brighthaupt SC, Stone EM, Rutkow L, McGinty EE.

Prev Med. 2019 Sep;126:105736. doi: 10.1016/j.ypmed.2019.05.024. Epub 2019 May 29.

PMID:
31152831
14.

Stigmatizing language in news media coverage of the opioid epidemic: Implications for public health.

McGinty EE, Stone EM, Kennedy-Hendricks A, Barry CL.

Prev Med. 2019 Jul;124:110-114. doi: 10.1016/j.ypmed.2019.03.018.

PMID:
31122614
15.

Development of a Molecularly Stable Gene Therapy Vector for the Treatment of RPGR-Associated X-Linked Retinitis Pigmentosa.

Giacalone JC, Andorf JL, Zhang Q, Burnight ER, Ochoa D, Reutzel AJ, Collins MM, Sheffield VC, Mullins RF, Han IC, Stone EM, Tucker BA.

Hum Gene Ther. 2019 Aug;30(8):967-974. doi: 10.1089/hum.2018.244.

PMID:
31106594
16.

Molecular characterization of foveal versus peripheral human retina by single-cell RNA sequencing.

Voigt AP, Whitmore SS, Flamme-Wiese MJ, Riker MJ, Wiley LA, Tucker BA, Stone EM, Mullins RF, Scheetz TE.

Exp Eye Res. 2019 Jul;184:234-242. doi: 10.1016/j.exer.2019.05.001. Epub 2019 May 8.

17.

Two-photon polymerized poly(caprolactone) retinal cell delivery scaffolds and their systemic and retinal biocompatibility.

Thompson JR, Worthington KS, Green BJ, Mullin NK, Jiao C, Kaalberg EE, Wiley LA, Han IC, Russell SR, Sohn EH, Guymon CA, Mullins RF, Stone EM, Tucker BA.

Acta Biomater. 2019 Aug;94:204-218. doi: 10.1016/j.actbio.2019.04.057. Epub 2019 May 3.

PMID:
31055121
18.

Choriocapillaris Degeneration in Geographic Atrophy.

Sohn EH, Flamme-Wiese MJ, Whitmore SS, Workalemahu G, Marneros AG, Boese EA, Kwon YH, Wang K, Abramoff MD, Tucker BA, Stone EM, Mullins RF.

Am J Pathol. 2019 Jul;189(7):1473-1480. doi: 10.1016/j.ajpath.2019.04.005. Epub 2019 Apr 30.

PMID:
31051169
19.

Swept-Source OCT of a Macular Coloboma in NMNAT1-Leber Congenital Amaurosis.

Han IC, Critser DB, Stone EM.

Ophthalmol Retina. 2018 Oct;2(10):1040. doi: 10.1016/j.oret.2018.07.009. Epub 2018 Oct 3. No abstract available.

PMID:
31047491
20.

Wide-Field Swept-Source OCT and Angiography in X-Linked Retinoschisis.

Han IC, Whitmore SS, Critser DB, Lee SY, DeLuca AP, Daggett HT, Affatigato LM, Mullins RF, Tucker BA, Drack AV, Stone EM.

Ophthalmol Retina. 2019 Feb;3(2):178-185. doi: 10.1016/j.oret.2018.09.006. Epub 2018 Sep 19.

PMID:
31014769
21.

Optimizing Donor Cellular Dissociation and Subretinal Injection Parameters for Stem Cell-Based Treatments.

Scruggs BA, Jiao C, Cranston CM, Kaalberg E, Wang K, Russell SR, Wiley LA, Mullins RF, Stone EM, Tucker BA, Sohn EH.

Stem Cells Transl Med. 2019 Aug;8(8):797-809. doi: 10.1002/sctm.18-0210. Epub 2019 Apr 19.

22.

Correction of NR2E3 Associated Enhanced S-cone Syndrome Patient-specific iPSCs using CRISPR-Cas9.

Bohrer LR, Wiley LA, Burnight ER, Cooke JA, Giacalone JC, Anfinson KR, Andorf JL, Mullins RF, Stone EM, Tucker BA.

Genes (Basel). 2019 Apr 5;10(4). pii: E278. doi: 10.3390/genes10040278.

23.

Two-color pupillometry in KCNV2 retinopathy.

Collison FT, Park JC, Fishman GA, Stone EM, McAnany JJ.

Doc Ophthalmol. 2019 Aug;139(1):11-20. doi: 10.1007/s10633-019-09691-w. Epub 2019 Mar 29.

PMID:
30927187
24.

Histochemical Analysis of Glaucoma Caused by a Myocilin Mutation in a Human Donor Eye.

van der Heide CJ, Alward WLM, Flamme-Wiese M, Riker M, Syed NA, Anderson MG, Carter K, Kuehn MH, Stone EM, Mullins RF, Fingert JH.

Ophthalmol Glaucoma. 2018 Sep-Oct;1(2):132-138. doi: 10.1016/j.ogla.2018.08.004. Epub 2018 Aug 17.

25.

General Medical Clinicians' Attitudes Toward People with Serious Mental Illness: A Scoping Review.

Stone EM, Chen LN, Daumit GL, Linden S, McGinty EE.

J Behav Health Serv Res. 2019 Oct;46(4):656-679. doi: 10.1007/s11414-019-09652-w. Review.

PMID:
30887413
26.

Myocilin Mutations in Patients With Normal-Tension Glaucoma.

Alward WLM, van der Heide C, Khanna CL, Roos BR, Sivaprasad S, Kam J, Ritch R, Lotery A, Igo RP Jr, Cooke Bailey JN, Stone EM, Scheetz TE, Kwon YH, Pasquale LR, Wiggs JL, Fingert JH; NEIGHBORHOOD Consortium.

JAMA Ophthalmol. 2019 May 1;137(5):559-563. doi: 10.1001/jamaophthalmol.2019.0005.

PMID:
30816940
27.

Disruption of RPGR protein interaction network is the common feature of RPGR missense variations that cause XLRP.

Zhang Q, Giacalone JC, Searby C, Stone EM, Tucker BA, Sheffield VC.

Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1353-1360. doi: 10.1073/pnas.1817639116. Epub 2019 Jan 8.

28.

Generation of an immortalized human choroid endothelial cell line (iChEC-1) using an endothelial cell specific promoter.

Giacalone JC, Miller MJ, Workalemahu G, Reutzel AJ, Ochoa D, Whitmore SS, Stone EM, Tucker BA, Mullins RF.

Microvasc Res. 2019 May;123:50-57. doi: 10.1016/j.mvr.2018.12.002. Epub 2018 Dec 18.

PMID:
30571950
29.

Correlation of Optical Coherence Tomography and Retinal Histology in Normal and Pro23His Retinal Degeneration Pig.

Cheng J, Sohn EH, Jiao C, Adler KL, Kaalberg EE, Russell SR, Mullins RF, Stone EM, Tucker BA, Han IC.

Transl Vis Sci Technol. 2018 Nov 30;7(6):18. doi: 10.1167/tvst.7.6.18. eCollection 2018 Nov.

30.

Care Coordination and Population Health Management Strategies and Challenges in a Behavioral Health Home Model.

Daumit GL, Stone EM, Kennedy-Hendricks A, Choksy S, Marsteller JA, McGinty EE.

Med Care. 2019 Jan;57(1):79-84. doi: 10.1097/MLR.0000000000001023.

31.

The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.

Mullins RF, McGwin G Jr, Searcey K, Clark ME, Kennedy EL, Curcio CA, Stone EM, Owsley C.

Ophthalmology. 2019 Apr;126(4):591-600. doi: 10.1016/j.ophtha.2018.10.037. Epub 2018 Oct 31.

PMID:
30389424
32.

CHOROIDAL NEOVASCULARIZATION IN NORTH CAROLINA MACULAR DYSTROPHY RESPONSIVE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.

Bakall B, Bryan JS 3rd, Stone EM, Small KW.

Retin Cases Brief Rep. 2018 Oct 31. doi: 10.1097/ICB.0000000000000838. [Epub ahead of print]

PMID:
30383557
33.

Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury.

Zeng S, Wen KK, Workalemahu G, Sohn EH, Wu M, Chirco KR, Flamme-Wiese MJ, Liu X, Stone EM, Tucker BA, Mullins RF.

Sci Rep. 2018 Sep 6;8(1):13387. doi: 10.1038/s41598-018-31846-z.

34.

Effect of Molecular Weight and Functionality on Acrylated Poly(caprolactone) for Stereolithography and Biomedical Applications.

Green BJ, Worthington KS, Thompson JR, Bunn SJ, Rethwisch M, Kaalberg EE, Jiao C, Wiley LA, Mullins RF, Stone EM, Sohn EH, Tucker BA, Guymon CA.

Biomacromolecules. 2018 Sep 10;19(9):3682-3692. doi: 10.1021/acs.biomac.8b00784. Epub 2018 Aug 9.

PMID:
30044915
35.

Evaluation of serum and ocular levels of membrane attack complex and C-reactive protein in CFH-genotyped human donors.

Chirco KR, Flamme-Wiese MJ, Wiley JS, Potempa LA, Stone EM, Tucker BA, Mullins RF.

Eye (Lond). 2018 Nov;32(11):1740-1742. doi: 10.1038/s41433-018-0170-8. Epub 2018 Jul 16.

36.

Public Willingness to Pay to Improve Services for Individuals With Serious Mental Illness.

Stone EM, McGinty EE.

Psychiatr Serv. 2018 Aug 1;69(8):938-941. doi: 10.1176/appi.ps.201800043. Epub 2018 May 8.

PMID:
29734922
37.

CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration.

Burnight ER, Giacalone JC, Cooke JA, Thompson JR, Bohrer LR, Chirco KR, Drack AV, Fingert JH, Worthington KS, Wiley LA, Mullins RF, Stone EM, Tucker BA.

Prog Retin Eye Res. 2018 Jul;65:28-49. doi: 10.1016/j.preteyeres.2018.03.003. Epub 2018 Mar 22. Review.

PMID:
29578069
38.

Expanded Retinal Disease Spectrum Associated With Autosomal Recessive Mutations in GUCY2D.

Stunkel ML, Brodie SE, Cideciyan AV, Pfeifer WL, Kennedy EL, Stone EM, Jacobson SG, Drack AV.

Am J Ophthalmol. 2018 Jun;190:58-68. doi: 10.1016/j.ajo.2018.03.021. Epub 2018 Mar 17.

PMID:
29559409
39.

CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.

Giacalone JC, Sharma TP, Burnight ER, Fingert JF, Mullins RF, Stone EM, Tucker BA.

Curr Protoc Stem Cell Biol. 2018 Feb 28;44:5B.7.1-5B.7.22. doi: 10.1002/cpsc.46.

40.

Public support for safe consumption sites and syringe services programs to combat the opioid epidemic.

McGinty EE, Barry CL, Stone EM, Niederdeppe J, Kennedy-Hendricks A, Linden S, Sherman SG.

Prev Med. 2018 Jun;111:73-77. doi: 10.1016/j.ypmed.2018.02.026. Epub 2018 Feb 23.

PMID:
29481827
41.

Keeping an Eye on Bardet-Biedl Syndrome: A Comprehensive Review of the Role of Bardet-Biedl Syndrome Genes in the Eye.

Weihbrecht K, Goar WA, Pak T, Garrison JE, DeLuca AP, Stone EM, Scheetz TE, Sheffield VC.

Med Res Arch. 2017 Sep;5(9). doi: 10.18103/mra.v5i9.1526. Epub 2017 Sep 18.

42.

CRISPR-Cas9-Mediated Correction of the 1.02 kb Common Deletion in CLN3 in Induced Pluripotent Stem Cells from Patients with Batten Disease.

Burnight ER, Bohrer LR, Giacalone JC, Klaahsen DL, Daggett HT, East JS, Madumba RA, Worthington KS, Mullins RF, Stone EM, Tucker BA, Wiley LA.

CRISPR J. 2018 Feb;1:75-87. doi: 10.1089/crispr.2017.0015.

43.

A novel mutation (LEU396ARG) in OPA1 is associated with a severe phenotype in a large dominant optic atrophy pedigree.

Schnieders MJ, Goar W, Griess M, Roos BR, Scheetz TE, Stone EM, Fingert JH.

Eye (Lond). 2018 Apr;32(4):843-845. doi: 10.1038/eye.2017.303. Epub 2018 Jan 19. No abstract available.

44.

Assessment of Adeno-Associated Virus Serotype Tropism in Human Retinal Explants.

Wiley LA, Burnight ER, Kaalberg EE, Jiao C, Riker MJ, Halder JA, Luse MA, Han IC, Russell SR, Sohn EH, Stone EM, Tucker BA, Mullins RF.

Hum Gene Ther. 2018 Apr;29(4):424-436. doi: 10.1089/hum.2017.179. Epub 2018 Feb 23.

45.

Genomic Organization of TBK1 Copy Number Variations in Glaucoma Patients.

DeLuca AP, Alward WLM, Liebmann J, Ritch R, Kawase K, Kwon YH, Robin AL, Stone EM, Scheetz TE, Fingert JH.

J Glaucoma. 2017 Dec;26(12):1063-1067. doi: 10.1097/IJG.0000000000000792.

46.

Evaluation of sFLT1 protein levels in human eyes with the FLT1 rs9943922 polymorphism.

Chirco KR, Lewis CJ, Scheetz TE, Johnston RM, Tucker BA, Stone EM, Fingert JH, Mullins RF.

Ophthalmic Genet. 2018 Jan-Feb;39(1):68-72. doi: 10.1080/13816810.2017.1369550. Epub 2017 Sep 26.

47.

Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy.

Wiley LA, Anfinson KR, Cranston CM, Kaalberg EE, Collins MM, Mullins RF, Stone EM, Tucker BA.

Curr Protoc Stem Cell Biol. 2017 Aug 14;42:4A.12.1-4A.12.14. doi: 10.1002/cpsc.30.

48.

EYS Mutations Causing Autosomal Recessive Retinitis Pigmentosa: Changes of Retinal Structure and Function with Disease Progression.

McGuigan DB, Heon E, Cideciyan AV, Ratnapriya R, Lu M, Sumaroka A, Roman AJ, Batmanabane V, Garafalo AV, Stone EM, Swaroop A, Jacobson SG.

Genes (Basel). 2017 Jul 12;8(7). pii: E178. doi: 10.3390/genes8070178.

49.

Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.

Burnight ER, Gupta M, Wiley LA, Anfinson KR, Tran A, Triboulet R, Hoffmann JM, Klaahsen DL, Andorf JL, Jiao C, Sohn EH, Adur MK, Ross JW, Mullins RF, Daley GQ, Schlaeger TM, Stone EM, Tucker BA.

Mol Ther. 2017 Sep 6;25(9):1999-2013. doi: 10.1016/j.ymthe.2017.05.015. Epub 2017 Jun 12.

50.

Clinically Focused Molecular Investigation of 1000 Consecutive Families with Inherited Retinal Disease.

Stone EM, Andorf JL, Whitmore SS, DeLuca AP, Giacalone JC, Streb LM, Braun TA, Mullins RF, Scheetz TE, Sheffield VC, Tucker BA.

Ophthalmology. 2017 Sep;124(9):1314-1331. doi: 10.1016/j.ophtha.2017.04.008. Epub 2017 May 27.

Supplemental Content

Loading ...
Support Center